New 3D map may help surgeons remove kidney tumors faster
NCT ID NCT06868186
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 2 times
Summary
This study tests a software tool called RUS NE that creates a 3D model of a patient's kidney tumor and nearby blood vessels. Surgeons use it as a navigation guide during robot-assisted partial nephrectomy. The trial involves 204 adults with kidney tumors up to 7 cm, split into two groups: one using the tool and one without. The main goal is to see if the tool can reduce surgery time by at least 10%.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
RUS NE surgical navigation software (a 3D planning tool for surgeons)
What this could lead to
If successful, this tool could help surgeons perform kidney tumor removal faster and more precisely, potentially reducing complications and recovery time.
What could go wrong
This is a mid-sized trial testing a navigation aid, not a new treatment. The benefit is a modest time reduction, and the tool may not improve patient outcomes or work for all tumor types.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center
RECRUITINGSeoul, South Korea
Contact Email: •••••@•••••
-
Chonnam National University Hospital
RECRUITINGKwangju, Jeollanam-do, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Samsung Medical Center
RECRUITINGSeoul, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Severance Hospital
RECRUITINGSeoul, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••